Quarterly report pursuant to Section 13 or 15(d)

Deferred Revenue (Details Narrative)

v3.5.0.2
Deferred Revenue (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Aug. 31, 2016
Sep. 30, 2016
Dec. 31, 2015
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
May 31, 2015
Deferred Revenue Arrangement [Line Items]              
Deferred revenue             $ 1,250,000
Revenue   $ 742,558   $ 170,454 $ 1,535,754 $ 284,090  
Cystic Fibrosis Foundation Therapeutics Inc [Member]              
Deferred Revenue Arrangement [Line Items]              
Amount received upon execution of award agreement $ 1,000,000   $ 1,250,000   $ 1,500,000